Company
Regencell Bioscience Holdings Ltd (RGC)
Standardized SEC financial data for Regencell Bioscience Holdings Ltd — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001829667 · NASDAQ · Medicinal Chemicals & Botanical Products.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $386K | $438K | $2.5M | $1.6M | $1.1M | $948K |
| SG&A expense | $312K | $941K | $5.1M | $4.4M | $3.5M | $2.8M |
| Operating income | -$812K | -$1.4M |
Standardized from Regencell Bioscience Holdings Ltd's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $387K | $59K | $6.4M | $1.6M | $3.0M | $2.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$727K | -$767K | -$5.3M | -$5.0M | -$4.0M | -$3.1M |
| Capital expenditures |
Get RGC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RGC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RGC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"